Arcadia Biosciences (NASDAQ:RKDA) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Arcadia Biosciences (NASDAQ:RKDA) in a report issued on Monday. The brokerage issued a sell rating on the basic materials company’s stock.

Arcadia Biosciences Stock Down 8.9 %

RKDA opened at $2.67 on Monday. The company has a market cap of $3.65 million, a price-to-earnings ratio of -0.62 and a beta of 0.78. The firm’s fifty day simple moving average is $4.02 and its two-hundred day simple moving average is $4.12. Arcadia Biosciences has a 52-week low of $1.85 and a 52-week high of $10.31.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Arcadia Biosciences stock. Geode Capital Management LLC purchased a new position in Arcadia Biosciences, Inc. (NASDAQ:RKDA) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 12,297 shares of the basic materials company’s stock, valued at approximately $73,000. Geode Capital Management LLC owned approximately 0.90% of Arcadia Biosciences at the end of the most recent quarter. Institutional investors own 17.73% of the company’s stock.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.